What question did this study set out to answer?

This study aimed to explore how JAK2 mutations and TPO enhance platelet adhesion via αIIbβ3 integrin.

December 8, 2025Blood

Platelet priming in MPN triggers pro-thrombotic intermediate affinity state in αIIbβ3 integrin

View Full Paper

Ask AI

Bookmark

Authors

Platelet priming by TPO enhances thrombus formation in MPN, suggesting a link to increased venous thrombosis risk.

This study aimed to explore how JAK2 mutations and TPO enhance platelet adhesion via αIIbβ3 integrin.
Investigated platelet function in a mouse model with JAK2V617F mutation.
Used inferior vena cava stenosis and femoral vein injury models for venous thrombosis study.
Conducted microfluidics studies on platelet behavior under flow conditions.
Analyzed platelet adhesion and thrombus formation using machine learning models, and developed a FRET assay to monitor αIIbβ3 integrin.
Evaluated the effect of romiplostim on platelet function in MPN patients and healthy subjects.
JAK2V617F-expressing mice showed significantly increased venous thrombosis compared to controls.
Platelets from JAK2V617F mice displayed a 2.7-fold increase in adhesion on fibrin, indicating pre-activated αIIbβ3.
FRET assays identified αIIbβ3 integrins in intermediate affinity state (E+H-) in JAK2V617F platelets.
Romiplostim treatment caused a 6-fold increase in E+H-αIIbβ3 and fibrin adhesion in WT platelets.
The induction of E+H-αIIbβ3 was sensitive to PI3K inhibition, highlighting a regulatory pathway for platelet function.

Wolfgang Bergmeier (2025) studied this question.

View Full Paper

Ask AI

Bookmark